IPO Guru

IPO Listed — 13 Feb 2026

Listing Price: ₹111 (+2.78% vs ₹108)

View GMP History →
Biopol Chemicals

Biopol Chemicals SME IPO Review

Biopol Chemicals SME IPO has been reviewed by 1 analyst, and the overall consensus is Strictly Avoid — carrying a score of 0. Out of the 1 analysts who have covered this IPO, 0 recommend subscribing while 1 advises caution or avoidance — reflecting a mixed view from the analyst community.

The issue is priced in the band of ₹102-108 per share , with a minimum application size of 1200 shares (minimum investment of approximately ₹129,600 at the upper band) . Subscription ran from 06 Feb 2026 to 10 Feb 2026. As of now, the grey market premium (GMP) for Biopol Chemicals SME IPO is quoting at ₹3 (3%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.

Analyst Sentiment

Analytical Score

How it's calculated?
Strictly Avoid
0 / 100

Recommend Subscribe

Based on 1 analyst reviews

0 / 1

Higher consensus indicates broader analyst agreement.

Analyst Review

Analyst Verdict View
Avoid

Latest IPO Reviews

Frequently Asked Questions

Should I apply for Biopol Chemicals SME IPO?

Based on analyst coverage tracked on this page, the overall verdict for Biopol Chemicals SME IPO is Strictly Avoid. Out of 1 analyst who have reviewed this IPO, 0 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.

What does the score of 0 mean for Biopol Chemicals SME IPO?

The score of 0 is an aggregate of all analyst ratings tracked for Biopol Chemicals SME IPO. A score in this range signals that most analysts are advising caution or outright avoidance. Scroll down to read individual analyst verdicts for more context.

What was the actual listing price of Biopol Chemicals SME IPO?

Biopol Chemicals SME IPO listed on February 13, 2026 at ₹111 , against the issue price of ₹108 — a gain of +2.78% (₹3 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Biopol Chemicals SME IPO?

Biopol Chemicals SME IPO was priced at ₹102-108 per share. The minimum lot size is 1200 shares, making the minimum investment approximately ₹129,600 at the upper end of the price band. Subscription ran from 06 Feb 2026 to 10 Feb 2026.

Explore Biopol Chemicals SME IPO Further

Track every stage of this IPO:

Discussion 0

💡
Commenting as
Markdown supported: **bold**, _italics_

No comments yet

Be the first to share your thoughts!

Advertisement
Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.